Epstein-Barr Virus: Forgotten Etiology of Hepatic Injury
Epstein-Barr virus infection may present with liver injury characterized by acute cholestatic hepatitis, as demonstrated in this case.
Hepatic Disease
Pharmacotherapies for Liver Fibrosis, NASH Resolution Ranked
Although NASH is a common cause of chronic liver disease, there is limited evidence surrounding its management.
T2DM Is Risk Factor for Liver Fibrosis Progression in NAFLD
In multivariate analysis, age, albumin concentration, T2DM independently tied to progression.
Prevalence of Alcoholic Fatty Liver Disease in the Unites States, 2001-2016
Prevalence of alcoholic fatty liver disease remained relatively unchanged from 2001 to 2016, but alcoholic fatty liver disease with fibrosis stage 2 and 3 or greater increased significantly.
Nurse-Led Program in Primary Care Can Improve Detection of Liver Disease
More incident cases identified in intervention arm with nurse-led primary care-based liver clinics.
Shared drug paraphernalia linked to hep C transmission
In a study, 24% of confiscated drug snorting straws tested positive for human blood.
Direct-acting antivirals in hepatitis C do not reduce hepatocellular carcinoma occurrence
Patients previously treated for HCC have a high risk of tumor recurrence in the long term.
Epclusa approved to treat chronic hepatitis C
The combination drug treats 6 strains of chronic hepatitis C.
Hepatitis C mortality increasing, now leading cause of death among all infectious diseases
The number of deaths associated with hepatitis C is higher than the total number of deaths resulting from 60 other infectious diseases.
Liver grafts from first-degree relatives do not increase recurrence risk
The source of a patient’s liver transplant did not significantly affect rates of disease recurrence.
- Loading...
Loading...
Loading... 
Loading...